Similar articles for PMID: 16134297

Year	Number of Results
1947	1
1994	3
1995	3
1996	1
1997	3
1998	5
1999	3
2000	3
2001	5
2002	4
2003	5
2004	11
2005	5
2006	6
2007	4
2009	3
2010	1
2011	1
2012	4
2013	12
2015	9
2016	6
2017	7
2018	11
2019	1
2020	1
2021	7
2022	13
2023	3
2024	1

1

[Von Hippel-Lindau disease: recent advances in genetics and clinical management].

Richard S, Parker F, Aghakhani N, Allegre G, Portier F, David P, Marsot-Dupuch K. Richard S, et al. J Neuroradiol. 2005 Jun;32(3):157-67. doi: 10.1016/s0150-9861(05)83133-5. J Neuroradiol. 2005. PMID: 16134297 Review. French.

2

Von Hippel-Lindau: how a rare disease illuminates cancer biology.

Richard S, Gardie B, Couvé S, Gad S. Richard S, et al. Semin Cancer Biol. 2013 Feb;23(1):26-37. doi: 10.1016/j.semcancer.2012.05.005. Epub 2012 May 30. Semin Cancer Biol. 2013. PMID: 22659535 Review.

3

von Hippel-Lindau disease: recent advances and therapeutic perspectives.

Richard S; French VHL Study Group. Richard S, et al. Expert Rev Anticancer Ther. 2003 Apr;3(2):215-33. doi: 10.1586/14737140.3.2.215. Expert Rev Anticancer Ther. 2003. PMID: 12722881 Review.

4

[Genetics and angiogenesis: the example of von Hippel-Lindau disease].

Richard S, Ladroue C, Gad S, Giraud S, Gardie B; Réseau national maladie de VHL et prédispositions héréditaires au cancer du rein de l'Institut national du cancer (INCa). Richard S, et al. Bull Cancer. 2007 Jul;94 Spec No:S170-9. Bull Cancer. 2007. PMID: 17846002 Review. French.

5

[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].

Richard S, Giraud S, Beroud C, Caron J, Penfornis F, Baudin E, Niccoli-Sire P, Murat A, Schlumberger M, Plouin PF, Conte-Devolx B. Richard S, et al. Ann Endocrinol (Paris). 1998;59(6):452-8. Ann Endocrinol (Paris). 1998. PMID: 10189987 Review. French.

6

Von Hippel-Lindau disease.

Chittiboina P, Lonser RR. Chittiboina P, et al. Handb Clin Neurol. 2015;132:139-56. doi: 10.1016/B978-0-444-62702-5.00010-X. Handb Clin Neurol. 2015. PMID: 26564077 Free PMC article. Review.

7

[Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].

Richard S, Martin S, David P, Decq P. Richard S, et al. Neurochirurgie. 1998 Nov;44(4):258-66. Neurochirurgie. 1998. PMID: 9864697 Review. French.

8

Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.

Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER. Zatyka M, et al. Cancer Res. 2002 Jul 1;62(13):3803-11. Cancer Res. 2002. PMID: 12097293

9

Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.

Jensen RL, Gillespie D, House P, Layfield L, Shelton C. Jensen RL, et al. J Neurosurg. 2004 Mar;100(3):488-97. doi: 10.3171/jns.2004.100.3.0488. J Neurosurg. 2004. PMID: 15035285

10

Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.

Richard S, David P, Marsot-Dupuch K, Giraud S, Béroud C, Resche F. Richard S, et al. Neurosurg Rev. 2000 Mar;23(1):1-22; discussion 23-4. doi: 10.1007/s101430050024. Neurosurg Rev. 2000. PMID: 10809480 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year